13D/13G Filings - Viracta Subsidiary Inc.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-01-10
4:35 pm
Unchanged
2022-06-08 13D Viracta Therapeutics, Inc.
VIRX
Schindel Yair Chaim 7,392,237
19.350%
0
(Unchanged)
Filing
History
2021-03-03
7:22 pm
Purchase
2021-02-25 13G Viracta Therapeutics, Inc.
VIRX
LVP LIFE SCIENCE VENTURES III L.P. 3,124,094
8.440%
3,124,094increase
(New Position)
Filing
History
2021-03-01
06:06 am
Purchase
2021-02-24 13D Viracta Therapeutics, Inc.
VIRX
Schindel Yair Chaim 7,392,237
19.980%
7,392,237increase
(New Position)
Filing
History